4-[5-[BIS-[2-(2-AMINO-2-CARBOXYETHYLSULFANYL)-ETHYL]-AMINO]-1-METHYL-1H-BENZOIMIDAZOL-2-YL]-BUTANOIC-ACID
Compound with spectra: 1 NMR
![4-[5-[BIS-[2-(2-AMINO-2-CARBOXYETHYLSULFANYL)-ETHYL]-AMINO]-1-METHYL-1H-BENZOIMIDAZOL-2-YL]-BUTANOIC-ACID](/api/compound/Gft8JPGSzUR.png?ph=true&h=300&w=458 "4-[5-[BIS-[2-(2-AMINO-2-CARBOXYETHYLSULFANYL)-ETHYL]-AMINO]-1-METHYL-1H-BENZOIMIDAZOL-2-YL]-BUTANOIC-ACID")
| SpectraBase Compound ID | Gft8JPGSzUR |
|---|---|
| InChI | InChI=1S/C22H33N5O6S2/c1-26-18-6-5-14(11-17(18)25-19(26)3-2-4-20(28)29)27(7-9-34-12-15(23)21(30)31)8-10-35-13-16(24)22(32)33/h5-6,11,15-16H,2-4,7-10,12-13,23-24H2,1H3,(H,28,29)(H,30,31)(H,32,33)/t15-,16-/m0/s1 |
| InChIKey | AHLRDSPXWDUJDF-HOTGVXAUSA-N |
| Mol Weight | 527.7 g/mol |
| Molecular Formula | C22H33N5O6S2 |
| Exact Mass | 527.187226 g/mol |
| Enantiomer InChIKey | AHLRDSPXWDUJDF-HZPDHXFCSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|
4-[5-[[(2-AMINO-2-CARBOXYETHYLSULFANYL)-ETHYL]-(2'-CHLOROETHYL)]-AMINO]-1-METHYL-1H-BENZOIMIDAZOL-2-YL]-BUTANOIC-ACID
2-furancarboxamide, N-[2-[5-(acetylamino)-1-methyl-1H-benzimidazol-2-yl]ethyl]tetrahydro-
2-furancarboxamide, tetrahydro-N-[2-[1-methyl-5-[(2-methyl-1-oxopropyl)amino]-1H-benzimidazol-2-yl]ethyl]-
N-{2-[1-methyl-5-(pentanoylamino)-1H-benzimidazol-2-yl]ethyl}benzamide
N-{2-[2-(benzoylamino)ethyl]-1-methyl-1H-benzimidazol-5-yl}-4-methylbenzamide
N-{2-[1-methyl-5-(propionylamino)-1H-benzimidazol-2-yl]ethyl}benzamide
2-furancarboxamide, tetrahydro-N-[2-[1-methyl-5-[[(phenylamino)carbonyl]amino]-1H-benzimidazol-2-yl]ethyl]-
N-[2-(1-methyl-5-nitro-1H-benzimidazol-2-yl)ethyl]benzenesulfonamide
butanamide, N-[2-[[(4,6-dimethyl-2-pyrimidinyl)thio]methyl]-1-methyl-1H-benzimidazol-5-yl]-
butanamide, 3-methyl-N-[1-methyl-2-(4-morpholinylmethyl)-1H-benzimidazol-5-yl]-
| Title | Journal or Book | Year |
|---|---|---|
| SYNTHESIS AND CHARACTERIZATION OF SOME NEW PHASE II METABOLITES OF THE ALKYLATOR BENDAMUSTINE AND THEIR IDENTIFICATION IN HUMAN BILE, URINE, AND PLASMA FROM PATIENTS WITH CHOLANGIOCARCINOMA | Drug Metabolism and Disposition | 2005 |